Comparing heparin monitoring methods in children with heart conditions
Part of Genetic & congenital, Heart & circulation clinical trials.
This study compares two ways of measuring how well the blood thinner heparin works in children after heart surgery in the ICU. The goal is to find the best method to keep the dose safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child between 0 and 17 years old.
- Your weight must be at least 3.5 kg (about 7.7 pounds).
- You must be in the heart ICU or a similar critical care unit after heart surgery or for a heart condition.
- You must be receiving a blood thinner called unfractionated heparin through a special IV line (central line).
- You must have both an arterial line and a central venous catheter already in place.
- Your parent or guardian must sign a consent form agreeing to the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether blood samples taken from a central line using either a syringe flush or a vacuum tube give the same heparin activity results as blood from a vein in the arm. It is designed for patients in the ICU who are on a steady heparin drip.
This study tests a blood-derived medicine (antithrombin) to help people who do not respond well to the blood thinner heparin during heart surgery. It aims to make surgery safer by improving blood thinning.
This study looks at how well a blood test (PTT) monitors the blood thinner heparin in hospital patients. If you are getting heparin through an IV, this research may help improve how your treatment is managed.
This study tests whether a blood thinner (LMWH) can help prevent dangerous blood clots in teens with a central line and infection or inflammation in the pediatric intensive care unit (PICU). It aims to find a safer, more personalized way to use preventive treatment.
This study looks at how well blood thinners (anticoagulants) and inflammation markers work in people having heart or blood vessel procedures. It aims to better monitor these treatments to improve patient safety.
This trial tests whether giving a blood thinner before placing a central line (a special IV) helps prevent clots in critically ill children. It could lower the risk of problems from the line.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.